Prashannata Khwaounjoo

Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients

Catherine Han, Prashannata Khwaounjoo, Dean H. Kilfoyle et al. · BMC Cancer · 2013 · 24 citations · Full text

Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand

Phyu Sin Aye, Sandar Tin Tin, Mark J. McKeage et al. · BMC Cancer · 2020 · 19 citations · Full text

EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand

Mark J. McKeage, Mark Elwood, Sandar Tin Tin et al. · Targeted Oncology · 2017 · 16 citations

Genetic Testing, Cancer Epidemiology, Egfr Mutation Testing +7

Screening for anaplastic lymphoma kinase (<i>ALK</i>) gene rearrangements in non‐small‐cell lung cancer in New Zealand

Mark J. McKeage, Sandar Tin Tin, Prashannata Khwaounjoo et al. · Internal Medicine Journal · 2019 · 16 citations

Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation

Catherine Han, Prashannata Khwaounjoo, Andrew Hill et al. · Scientific Reports · 2017 · 13 citations · Full text